Efficacy of the Mirasol pathogen reduction technology system against severe fever with thrombocytopenia syndrome virus (SFTSV)

Publisher： John Wiley & Sons Inc

E-ISSN： 1423-0410|109|4|417-419

ISSN： 0042-9007

Source： VOX SANGUINIS, Vol.109, Iss.4, 2015-11, pp. : 417-419

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Buffy Coat Platelets in Platelet Additive Solution with the Mirasol® Pathogen Reduction Technology System

By  

Transfusion Medicine and Hemotherapy, Vol. 40, Iss. 1, 2013-01 ,pp. : 44-48

Karger

Access to resources Recommend Favorite

A study of seroprevalence and rates of asymptomatic viremia of severe fever with thrombocytopenia syndrome virus among Chinese blood donors

By  

TRANSFUSION, Vol. 55, Iss. 5, 2015-05 ,pp. : 965-971

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of Different Preparation Procedures of Pathogen Reduction Technology(Mirasol®)-Treated Platelets Collected by Plateletpheresis

By  

Transfusion Medicine and Hemotherapy, Vol. 36, Iss. 5, 2009-08 ,pp. : 309-315

Karger

Access to resources Recommend Favorite

Occupational Severe Fever With Thrombocytopenia Syndrome Following Needle-Stick Injury

By  

Infection Control & Hospital Epidemiology, Vol. 38, Iss. 6, 2017-04 ,pp. : 760-762

Cambridge University Press

Access to resources Recommend Favorite

Treatment of Platelet Concentrates with the Mirasol Pathogen Inactivation System Modulates Platelet Oxidative Stress and NF-κB Activation

By  

Transfusion Medicine and Hemotherapy, Vol. 42, Iss. 3, 2015-05 ,pp. : 167-173

Karger

Access to resources Recommend Favorite